Analog Devices To Rally Around 81%? Here Are 10 Top Analyst Forecasts For Monday - Chipotle Mexican Grill
Wall Street analysts updated price targets and ratings for several companies. Baird cut Chipotle's (CMG) target to $40 and downgraded it to Neutral. HC Wainwright raised LB Pharmaceuticals' (LBRX) target to $60. BTIG increased AtriCure's (ATRC) target to $55. Baird also raised Analog Devices' (ADI) target to $675 and upgraded Darden Restaurants' (DRI) target to $250. Other notable changes include updates for Black Rock Coffee Bar (BRCB), Marti Technologies (MRT), Alkami Technology (ALKT), Chenie
How this was made
The 30-second read
Why it matters
The revisions provide fresh guidance cues for traders, though the magnitude varies across names.
Market read
Price target changes can influence short-term trading decisions and sentiment for the listed stocks.
What to watch
Potential macro headwinds not reflected in analyst revisions.
Background
Analyst firms updated price targets and ratings for a set of US-listed companies following recent market activity.
Ticker impact
Baird cut Chipotle price target to $40 and downgraded to Neutral.
Modest short-term decline
Target cut reflects weaker outlook.
HC Wainwright raised LB Pharmaceuticals target to $60, maintaining Buy.
Potential modest rally
Higher target signals improved expectations.
BTIG raised AtriCure target to $55, maintaining Buy.
Possible short-term gain
Analyst confidence rises.
Baird cut Black Rock Coffee Bar target to $10, downgrading to Neutral.
Likely price dip
Target cut reflects weaker outlook.
Cantor Fitzgerald lowered Marti Technologies target to $2.2, keeping Neutral.
Flat to slight decline
Small target change.
Needham raised Alkami Technology target to $25, maintaining Buy.
Potential modest rise
Target increase signals confidence.
Baird raised Darden Restaurants target to $250, upgrading to Outperform.
Possible rally
Upgrade indicates stronger prospects.
Baird raised Analog Devices target to $675, maintaining Outperform.
Potential significant upside
Large target increase reflects bullish view.
Market effects
Analyst target revisions may slightly shift sector sentiment for consumer discretionary and technology.
US market focus; limited regional effect.
Minimal global impact beyond US equities.
Counterpoint
Target cuts may be overdone if earnings later beat expectations.
Key entities
- Analyst FirmBaird
Provided multiple target cuts and upgrades.
- Analyst FirmHC Wainwright
Raised target for LB Pharmaceuticals.
